Document is current
Any future updates will be listed below
-
Authors
Shen, Chenxiao
Du, Zijing
Lai, Chunran
Su, Ting
Wu, Qiaowei
Chen, Yanlei
Fang, Ying
Zhu, Zhuoting
Zhang, Xiayin
Yu, Honghua
-
Funding
Funding for this research was provided by:
Scientific Research Project of Traditional Chinese Medicine Bureau of Guangdong Province (20231012)
China Postdoctoral Science Foundation (2024T170185)
National Natural Science Foundation of China (82301260, U24A20707)
Guang-dong Basic and Applied Basic Research Foundation (2023B1515120028)
Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients with Persistent Diabetic Macular Edema (2024-29)
- License Information
-
More Information
Article History
Received: 4 March 2025
Accepted: 16 May 2025
First Online: 18 June 2025
Declarations
:
: The UK Biobank study was approved by the UK National Health Service National Research Ethics Service (Ref 11/NW/0382), and informed consent was obtained from all participants.
: Written informed consent for publication was obtained from all participants.
: The authors declare no competing interests.
